United States · Bill · S
S. 3754 (115th)
CURE High Drug Prices Act
Introduced
13 December 2018
Last action
—
Status
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsors
—
Subjects
Discovery layer
Source updated
11 August 2025
Summary
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of certain prescription drugs that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in Senate (text)
Introduced in Senate · EN · 13 December 2018
Introduced in Senate (PDF)
Introduced in Senate · EN · 13 December 2018
Introduced in Senate
summary · EN · 13 December 2018
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/115th-congress/senate-bill/3754
- Open data entity: https://api.congress.gov/v3/bill/115/s/3754